Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The PEHO syndrome.

R Riikonen1

  • 1Department of Child Neurology, University Hospital, P.O. Box 1777, Kuopio 70211, Finland. raili.riikonen@uku.fi

Brain & Development
|November 10, 2001
PubMed
Summary
This summary is machine-generated.

Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy (PEHO) syndrome involves reduced insulin-like growth factor 1 (IGF-1) and increased nitric oxide (NO) production. These findings offer new insights into PEHO syndrome

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for asthma after infant bronchiolitis.

Allergy·2017
Same author

Long-term outcome in pyridoxine-responsive infantile epilepsy.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2015
Same author

Effects of fluoxetine treatment on striatal dopamine transporter binding and cerebrospinal fluid insulin-like growth factor-1 in children with autism.

Neuropediatrics·2011
Same author

Cerebrospinal fluid insulin-like growth factor-1, insulin growth factor binding protein-2 or nitric oxide are not increased in MS or ALS.

Acta neurologica Scandinavica·2004
Same author

Reversed visual field constrictions in children after vigabatrin withdrawal--true retinal recovery or improved test performance only?

Seizure·2001
Same author

Epidemiological data of West syndrome in Finland.

Brain & development·2001
Same journal

Receptor-specific dopaminergic imbalance and sensory gating in Lesch-Nyhan syndrome.

Brain & development·2026
Same journal

From weather stations to the home environment: Refining seizure prediction in pediatric drug-resistant epilepsy.

Brain & development·2026
Same journal

Pediatric GBS-myelitis overlap syndrome: Severe phenotype, treatment response, and neurological outcomes.

Brain & development·2026
Same journal

Aspartoacylase (ASPA) gene mutations and neuroimaging features in Iranian patients with Canavan disease: a descriptive study.

Brain & development·2026
Same journal

Third nationwide survey of bilirubin encephalopathy in preterm infants in Japan.

Brain & development·2026
Same journal

Urine protein/osmolality and creatinine/osmolality ratios for assessing proteinuria and motor function in children with spinal muscular atrophy.

Brain & development·2026
See all related articles

Area of Science:

  • Pediatric Neurology
  • Neurodegenerative Diseases
  • Biochemistry

Background:

  • Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy (PEHO) syndrome is a rare pediatric disorder of unknown etiology.
  • Pathological findings include progressive atrophy of the cerebellum, brainstem, and optic nerves.
  • Nitric oxide (NO) is implicated in seizure activity and neurodegeneration, while insulin-like growth factor 1 (IGF-1) may offer neuroprotection.

Purpose of the Study:

  • To investigate the hypothesis that NO production is elevated and IGF-1 production is reduced in patients with PEHO syndrome.
  • To explore the potential correlation between NO production and reduced IGF-1 levels in the brain.

Main Methods:

  • Cerebrospinal fluid (CSF) was collected from patients with PEHO syndrome and control subjects.

Related Experiment Videos

  • Insulin-like growth factor 1 (IGF-1) levels were measured using a radioimmunoassay (RIA) kit.
  • Nitrite/nitrate levels, indicators of NO production, were determined using the Griess calorimetric method.

    • Main Results:

    • Patients with PEHO syndrome exhibited significantly reduced levels of IGF-1 in their CSF compared to controls.
    • Markedly elevated levels of nitrite/nitrate were observed in the CSF of PEHO syndrome patients.
    • These findings represent the first identified biochemical abnormalities in PEHO syndrome.

    Conclusions:

    • The study suggests defective IGF-1 production may be linked to the neurodegeneration observed in PEHO syndrome.
    • Increased NO production likely reflects the seizure activity and/or neurodegeneration characteristic of the disease.
    • Further research into these biochemical markers could enhance understanding and potentially guide future therapeutic strategies for PEHO syndrome.